Second, network pharmacology predicted that the molecular mechanism of AECRs in the treatment of thrombocytopenia was closely related to the PI3K/AKT, JAK/STAT, RAS, MAPK, and mTOR pathways. Here, MTOR is linked to Thrombocytopenia.